{"id":203528,"date":"2025-12-23T00:00:00","date_gmt":"2025-12-23T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041117-medtech-interventional-cardiology-devices-market\/"},"modified":"2026-03-31T10:09:18","modified_gmt":"2026-03-31T10:09:18","slug":"47042542-medtech-interventional-cardiology-devices-market-insights-united-states","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042542-medtech-interventional-cardiology-devices-market-insights-united-states\/","title":{"rendered":"Interventional Cardiology Devices &#8211; Market Insights &#8211; United States"},"content":{"rendered":"<p>The US interventional cardiology device market is highly competitive and poised for growth, driven by increasing <abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> volumes for complex <abbr title=\"Coronary Artery Disease\">CAD<\/abbr> cases and the adoption of innovative devices and technologies. Favorable clinical evidence and new trials investigating devices, particularly for coronary <abbr data-abbreviation-entity=\"10133\" title=\"Intravascular Lithotripsy\">IVL<\/abbr>, will continue to support the market. Additionally, the introduction of novel products and diagnostic methods is expected to broaden the eligible patient population and sustain growth in the coming years.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for <abbr title=\"Interventional Cardiology\">IC<\/abbr> devices in the US, with market projections from 2019 through 2034.<\/p>\n<p class=\"question-statement\"><strong>The coronary stent market is a highly competitive space, with the leading companies continuing to launch updates to their flagship devices.<\/strong><\/p>\n<p>What are the market share dynamics among the three major competitors in the highly lucrative <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr> device market?<\/p>\n<p>Which competitive strategies are the major companies implementing to gain market share in this market?<\/p>\n<p>What is the developmental pipeline for next-generation of <abbr title=\"Bioresorbable Scaffold(s)\">BRS<\/abbr> and which technologies are companies utilizing as a stopgap until <abbr title=\"Bioresorbable Scaffold(s)\">BRS<\/abbr> technology is ready for patient use?<\/p>\n<p><strong>The expansion of intravascular lithotripsy use is bolstering the <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market.<\/strong><\/p>\n<p>Which new competitors are entering this space and initiating trials to build clinical evidence?<\/p>\n<p>How has the commercialization of coronary lithotripsy impacted the use of other products in the interventional cardiology space?<\/p>\n<p>How is reimbursement changing for coronary lithotripsy, and how will this affect adoption of this technology?<\/p>\n<p class=\"question-statement\"><strong>The adoption of premium-priced devices and new diagnostic methods will impact procedural success rates and overall <abbr data-abbreviation-entity=\"8917\" title=\"Percutaneous Coronary Intervention\">PCI<\/abbr> volumes in the US <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market.<\/strong><\/p>\n<p class=\"question-statement\">What is the impact of the latest generation of alternative coronary physiology modalities, such imaging-based <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr><sub>angio<\/sub> and <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr><sub><abbr title=\"Computed Tomography\">CT<\/abbr><\/sub>, on existing intravascular imaging technologies, including traditional <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr> and <abbr title=\"Intravascular Ultrasound\">IVUS<\/abbr>?<\/p>\n<p>What is the expected impact of emerging balloon-based technologies such as <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s?<\/p>\n<p>How will new clinical trial results impact <abbr title=\"Interventional Cardiology\">IC<\/abbr> device segments, procedures, competitors, and products?<\/p>\n","protected":false},"template":"","class_list":["post-203528","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-interventional-cardiology-devices","medtech-geography-united-states","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/203528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/203528\/revisions"}],"predecessor-version":[{"id":571865,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/203528\/revisions\/571865"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=203528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}